The Potential of Single Nucleotide Polymorphisms (SNPs) as Biomarkers and Their Association with the Increased Risk of Coronary Heart Disease: A Systematic Review

Abstract

Human genetic analyses and epidemiological studies showed a potential association between several types of gene polymorphism and the development of coronary heart disease (CHD). Many studies on this pertinent topic need to be investigated further to reach an evidence-based conclusion. Therefore, in this current review, we describe several types of gene polymorphisms that are potentially linked to CHD. A systematic review using the databases EBSCO, PubMed, and ScienceDirect databases was searched until October of 2022 to find relevant studies on the topic of gene polymorphisms on risk factors for CHD, especially for the factors associated with single nucleotide polymorphisms (SNPs). The risk of bias and quality assessment was evaluated by Joanna Briggs Institute (JBI) guidelines. From keyword search results, a total of 6243 articles were identified, which were subsequently narrowed to 14 articles using prespecified inclusion criteria. The results suggested that there were 33 single nucleotide polymorphisms (SNPs) that can potentially increase the risk factors and clinical symptoms of CHD. This study also indicated that gene polymorphisms had a potential role in increasing CHD risk factors that were causally associated with atherosclerosis, increased homocysteine, immune/inflammatory response, Low-Density Lipoprotein (LDL), arterial lesions, and reduction of therapeutic effectiveness. In conclusion, the findings of this study indicate that SNPs may increase risk factors for CHD and SNPs show different effects between individuals. This demonstrates that knowledge of SNPs on CHD risk factors can be used to develop biomarkers for diagnostics and therapeutic response prediction to decide successful therapy and become the basis for defining personalized medicine in future.

Moving from GWAS signals to rare functional variation in inflammatory bowel disease through application of GenePy2 as a potential DNA biomarker

“…Both single DNA variant and aggregated effects of multiple variants has been utilized for disease risk stratifications[38, 39], but a biomarker from rare and functional genomic variants is missing for complex disease despite their potentially direct causal effect with disease. Filling the gap relies on a large cohort, but big genomic data is enriched with issues of complex variations, e.g.…”

Pangenomics of the cichlid species (Oreochromis niloticus) reveals genetic admixture ancestry with potential for aquaculture improvement in Kenya

“…Whereas there are methods for the introgression of new alleles in to fish to improve productivity and stress tolerance, there are controversies regarding the safety of consumption of genetically modified organisms, health, and environmental impact. The attendant effect is however not investigated conclusively though they are thought to have far-reaching ramifications such as the rise in cancer cases in human beings (Sitinjak et al, 2023). Introduction of genetically modified fish in the natural ecosystem has been found to alter the population structure of the wild fishes (Devlin et al, 2004).…”

The Genotypic Imperative: Unraveling Disease-Permittivity in Functional Modules of Complex Diseases

“…Therefore, we present a non-linear model of pairwise gene interactions where the Bell test is violated. In this model, the measurements are defined by SNPs, and the expression rate corresponds to the essence of SNP interactions [14][15][16][17]. As a result, we contend that this model setting furnishes, at the very least, a modest proof demonstrating the existence of a connection between genes beyond what is determined by the genotype in the modeling of complex diseases.…”